ArticleFrontiers in pediatrics2026
Childhood-onset systemic lupus erythematosus presenting with growth retardation and delayed puberty: a case report.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Childhood-onset systemic lupus erythematosus (cSLE) is a chronic, multisystem autoimmune disease characterized by marked clinical heterogeneity and substantial morbidity. Although rash, arthritis, and renal involvement are common manifestations, atypical presentations may delay diagnosis. In rare cases, growth retardation and delayed puberty may precede typical systemic features, posing a diagnostic challenge. We report the case of a 12-year-old Chinese girl who presented to the endocrinology clinic with progressive growth retardation and delayed pubertal development. Comprehensive growth assessment demonstrated discordance among height velocity, weight gain, and pubertal progression. Further evaluation revealed proteinuria, hypoalbuminemia, generalized lymphadenopathy, and immunological abnormalities, leading to a diagnosis of cSLE. Following immunosuppressive therapy, systemic manifestations improved and laboratory indices gradually normalized; however, longitudinal follow-up showed that impairment in growth and pubertal progression persisted despite disease control. This case highlights that cSLE, although a rare cause of growth retardation and delayed puberty, should be considered in adolescents with unexplained short stature or pubertal delay, particularly when accompanied by proteinuria or immunological abnormalities. Early recognition and multidisciplinary management are essential to improve long-term growth and overall clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.